ALLR · Allarity Therapeutics, Inc. · Executive Compensation
Market Cap
$13.95M
Shares
15.91M
Volume · Oct 20
108.54K
Avg daily vol (3M)
102.87K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Thomas H. Jensen | Chief Executive Officer | $1,458,950 |
| Jeremy R. Graff | President and Chief Development Officer | $908,818 |
| Alexander Epshinsky | Former Chief Financial Officer | $383,546 |
| Steen Knudsen | Chief Scientific Officer | $236,802 |
| Jeffrey S. Ervin | Chief Financial Officer | $158,531 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Thomas H. Jensen | Chief Executive Officer | $791,600 |
| Jeremy R. Graff | President and Chief Development Officer | $447,923 |
| Alexander Epshinsky | Chief Financial Officer | $349,397 |
| Marie Foegh | Former Chief Medical Officer | $250,470 |
| Joan Y. Brown | Former Chief Financial Officer | $250,000 |
| James G. Cullem | Former Chief Executive Officer | $249,155 |
| Steen Knudsen | Chief Scientific Officer | $140,937 |
| Jeffrey S. Ervin | Chief Financial Officer | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| James G. Cullem | Former Chief Executive Officer | $523,812 |
| Marie Foegh | Former Chief Medical Officer | $365,471 |
| Steen Knudsen | Chief Scientific Officer | $266,215 |
| Joan Y. Brown | Former Chief Financial Officer | $250,000 |
| Thomas H. Jensen | Chief Executive Officer | $24,720 |
| Alexander Epshinsky | Chief Financial Officer | — |
| Jeremy R. Graff | President and Chief Development Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Steve R. Carchedi | Former Chief Executive Officer | $532,359 |
| Steen Knudsen | Chief Scientific Officer | $372,426 |
| James G. Cullem | Former Chief Executive Officer and Former Chief Business Officer | $343,410 |
| Marie Foegh | Former Chief Medical Officer | $340,309 |
| Jens E. Knudsen | Former Chief Financial Officer | $333,633 |
| Joan Y. Brown | Chief Financial Officer, Director of Financial Reporting | $180,000 |
| Thomas H. Jensen | Chief Executive Officer, Corporate Secretary, and Senior Vice President, Investor Relations | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Steve R. Carchedi | former Chief Executive Officer | $4,466,219 |
| James G. Cullem | Senior Vice President/Chief Business Officer | $1,831,082 |
| Marie Foegh | Chief Medical Officer | $1,290,268 |
| Jens E. Knudsen | former Chief Financial Officer | $583,343 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Steve R. Carchedi | former Chief Executive Officer | $718,278 |
| James G. Cullem | Senior Vice President/Chief Business Officer | $393,515 |
| Marie Foegh | Chief Medical Officer | $288,000 |
| Jens E. Knudsen | former Chief Financial Officer | $272,334 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jeffrey S. Ervin | Chief Financial Officer | Appointed | 2025-07-07 |
| Alexander Epshinsky | Chief Financial Officer | Resigned | 2025-07-07 |
| Jesper Høiland | director | Appointed | 2025-06-11 |
| Joseph W. Vazzano | director | Resigned | 2025-06-11 |
| Thomas H. Jensen | Class III director | Appointed | 2025-04-16 |
| Thomas H. Jensen | Class I director | Resigned | 2025-04-16 |
| Jesper Høiland | Strategic Advisor | Appointed | 2024-10-04 |
| Jose Iglesias, M.D. | Consultant Chief Medical Officer | Appointed | 2024-10-04 |
| Jeremy R. Graff, Ph.D. | President and Chief Development Officer | Appointed | 2024-10-04 |
| Jeremy R. Graff | President and Chief Development Officer | Appointed | 2024-10-04 |
| Alexander Epshinsky | Chief Financial Officer | Appointed | 2024-09-13 |
| Joan Y. Brown | Chief Financial Officer | Resigned | 2024-09-13 |
| Laura E. Benjamin | Class II director | Appointed | 2024-09-09 |
| Gerald W. McLaughlin | Class II director | Appointed | 2024-09-09 |
| Marie Foegh, M.D. | Chief Medical Officer | Terminated | 2024-03-04 |
| James G. Cullem | Chief Executive Officer | Terminated | 2024-02-01 |
| James G. Cullem | member of our Board | Resigned | 2024-02-01 |
| Thomas Jensen | Chief Executive Officer | Appointed | 2023-12-11 |
| James Cullem | Chief Executive Officer | Terminated | 2023-12-11 |
| Laura Benjamin | member of the Audit Committee and Compensation Committee of the Board | Appointed | 2023-08-11 |
| Robert Oliver | director | Resigned | 2023-08-11 |
| Robert Oliver | Class III Director | Appointed | 2023-07-27 |
| Laura Benjamin | Class II Director | Appointed | 2023-07-27 |
| Joe Vazzano | Class I Director | Appointed | 2023-07-27 |
| David Roth | director | Resigned | 2023-07-27 |
Leadership
- Steve R. Carchedi CEO
- Thomas H. Jensen CEO, Board Member
- Thomas Jensen CEO, Board Member
- Gerald W. McLaughlin Chairman, Board Member
- Alexander Epshinsky CFO
- Jeffrey S. Ervin CFO
- Jens Erik Knudsen CFO
- Joan Brown CFO
- Joan Y. Brown CFO
- Dr. David Roth Board Member
- James G. Cullem Board Member
- Jerry McLaughlin Board Member
- Jesper Hoiland Board Member
- Jesper Høiland Board Member
- Joe Vazzano Board Member
- Laura Benjamin Board Member
- Laura E. Benjamin Board Member
- Robert Oliver Board Member